BNB$660.14+0.51%BRENT$93.46-0.34%BTC$74,843+0.56%COPPER$6.54+1.24%DJI$52,759-1.32%DOGE$0.0821+1.09%DXY98.74-0.15%ETH$2,345+0.17%GOLD$4,545+0.65%NDX$29,213-0.72%SILVER$69.13+1.54%SOL$89.07+0.15%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$660.14+0.51%BRENT$93.46-0.34%BTC$74,843+0.56%COPPER$6.54+1.24%DJI$52,759-1.32%DOGE$0.0821+1.09%DXY98.74-0.15%ETH$2,345+0.17%GOLD$4,545+0.65%NDX$29,213-0.72%SILVER$69.13+1.54%SOL$89.07+0.15%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 80%

Elite Pharmaceuticals Sets 2028 Launch for New Anticoagulant

Key takeaways

  • Elite Pharmaceuticals has announced a target launch year of 2028 for its new anticoagulant as it progresses with its NASDAQ uplisting plans.
#Pharmaceuticals#NASDAQ#Anticoagulants

Analysis

Elite Pharmaceuticals has announced a target launch year of 2028 for its new anticoagulant as it progresses with its NASDAQ uplisting plans.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.